Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity

HPB

Volumn 14, Issue 5, 2012, Pages 333-340

  Pilgrim, Charles H C ^a,d   Satgunaseelan, Laveniya ^d   Pham, Alan ^d   Murray, William ^b   Link, Emma ^a   Smith, Marty ^d   Usatoff, Val ^d   Evans, Peter M ^d   Banting, Simon ^a   Thomson, Benjamin N ^a   Phillips, Wayne A ^a   Michael, Michael ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

chemotherapy; chemotherapy < liver; colorectal carcinoma; colorectal metastases < liver; hepatectomy; perioperative morbidity

Indexed keywords

ADULT; AGED; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED HEPATIC INJURY; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; MORBIDITY; PREOPERATIVE TREATMENT; SINUSOIDAL INJURY; STEATOHEPATITIS; STEATOSIS; TREATMENT OUTCOME;

EID: 84859702946     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00454.x     Document Type: Article

References (20)

1. Kopetz S, Vauthey JN,. (2008) Perioperative chemotherapy for resectable hepatic metastases. Lancet 371: 963-965. (Pubitemid 351389517)
2. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al,. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): randomised controlled trial. Lancet 371: 1007-1016. (Pubitemid 351392040)
3. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK,. (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94: 274-286. (Pubitemid 46423843)
4. Makowiec F, Mohrle S, Neeff H, Drognitz O, Illerhaus G, Opitz OG, et al,. (2011) Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases. J Gastrointest Surg 15: 153-164.
5. Morris-Stiff G, Tan YM, Vauthey JN,. (2008) Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34: 609-614. (Pubitemid 351671976)
6. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al,. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072. (Pubitemid 46622116)
7. Khan AZ, Morris-Stiff G, Makuuchi M,. (2008) Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 16: 137-144.
8. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al,. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466. (Pubitemid 38444550)
9. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, et al,. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24: 4983-4990. (Pubitemid 46631400)
10. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al,. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247: 118-124.
11. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE,. (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39: 1647-1654. (Pubitemid 38702666)
12. Mendler MH, Kanel G, Govindarajan S,. (2005) Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Liver Int 25: 294-304.
13. Neuschwander-Tetri BA, Caldwell SH,. (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219. (Pubitemid 36538699)
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
15. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al,. (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250: 187-196.
16. Hussaini SH, Farrington EA,. (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 6: 673-684. (Pubitemid 351308279)
17. Salt WB, 2nd,. (2004) Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. J Insur Med 36: 27-41.
18. Day CP, James OF,. (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27: 1463-1466. (Pubitemid 28264666)
19. Dixon JB, Bhathal PS, O'Brien PE,. (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121: 91-100. (Pubitemid 32591518)
20. Mehta NN, Ravikumar R, Coldham CA, Buckels JA, Hubscher SG, Bramhall SR, et al,. (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34: 782-786.